Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

Rights & Permissions Free Resources Display this book on your site! Related Titles Calling the Shots: Immunization Finance Policies and Practices Financing Vaccines in the 21st Century:Assuring Access and Availability Other Related Titles Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices (1999) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Summary." Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices. Washington, DC: The National Academies Press, 1999. Please select a format: Page 1   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices SUMMARY Immunization provides valuable individual protection and an essential community benefit by preventing serious disease. Even high levels of primary care, however, do not guarantee that individuals are immunized. Building and sustaining an effective delivery system that can uniformly and consistently achieve high levels of immunization coverage (> 90 percent) for increasing numbers of vaccines presents both clinical challenges as well as complex management tasks. Finance strategies to address this challenge must constantly adapt to new scientific developments; changes in social, health, and economic conditions (including population migrations); and shifting roles in the balance of federal, state, and local responsibilities in the administration of health care systems. The Institute of Medicine (IOM) has been asked by the U.S. Senate Appropriations Committee to examine the nature and cost of the federal role in supporting a national immunization policy. The IOM study, to be completed in May 2000, will review the impact of federal funds on immunization rates and will eventually recommend an appropriate level of future federal investment in achieving national immunization goals, especially in the area of infrastructure support beyond vaccine purchase and delivery. As part of this effort, the committee has been asked by the Centers for Disease Control and Prevention (the study sponsor) to address two specific concerns in an interim report: ( 1) the experience with carryover (unobligated funds) in the administration of the Section 317 program; and (2) the impact of the new Children 's Health Insurance Program on the need for federal Section 317 funds for both core function initiatives and vaccine purchase. During the past decade Congress has reconfigured the federal involvement in national immunization policy through a series of initiatives focused on two objectives: (1) the improvement of vaccine purchase and delivery systems for disadvantaged children, and (2) the strengthening of infrastructure efforts in areas such as disease surveillance, public education, information management, public–private sector collaboration, and performance assessment. As a result of these initiatives, federal funding went through a major and rapid Page 1 Front Matter (R1-R4) Table of Contents (R5-R5) Summary (1-1) Introduction (2-4) The Carryover Issue in Section 317 Expenditures (5-6) The Impact of the State Children's Health Insurance (7-8) Next Steps (9-10) References (11-11) Notes (12-13) Appendixes (14-18) Committee Biographies (19-21)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 1
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices SUMMARY Immunization provides valuable individual protection and an essential community benefit by preventing serious disease. Even high levels of primary care, however, do not guarantee that individuals are immunized. Building and sustaining an effective delivery system that can uniformly and consistently achieve high levels of immunization coverage (> 90 percent) for increasing numbers of vaccines presents both clinical challenges as well as complex management tasks. Finance strategies to address this challenge must constantly adapt to new scientific developments; changes in social, health, and economic conditions (including population migrations); and shifting roles in the balance of federal, state, and local responsibilities in the administration of health care systems. The Institute of Medicine (IOM) has been asked by the U.S. Senate Appropriations Committee to examine the nature and cost of the federal role in supporting a national immunization policy. The IOM study, to be completed in May 2000, will review the impact of federal funds on immunization rates and will eventually recommend an appropriate level of future federal investment in achieving national immunization goals, especially in the area of infrastructure support beyond vaccine purchase and delivery. As part of this effort, the committee has been asked by the Centers for Disease Control and Prevention (the study sponsor) to address two specific concerns in an interim report: ( 1) the experience with carryover (unobligated funds) in the administration of the Section 317 program; and (2) the impact of the new Children 's Health Insurance Program on the need for federal Section 317 funds for both core function initiatives and vaccine purchase. During the past decade Congress has reconfigured the federal involvement in national immunization policy through a series of initiatives focused on two objectives: (1) the improvement of vaccine purchase and delivery systems for disadvantaged children, and (2) the strengthening of infrastructure efforts in areas such as disease surveillance, public education, information management, public–private sector collaboration, and performance assessment. As a result of these initiatives, federal funding went through a major and rapid

Representative terms from entire chapter:

national immunization